MSB 6.57% 99.5¢ mesoblast limited

ring that broker back , page-3

  1. 333 Posts.
    Vinn

    wanted to get your take on the clinical trial results for the cardiac stem cells that seems to be overshadowing mesoblast's trial results.

    based on the impressive results, could this could cardiac stem cell technology be a serious competitor to Revascor?

    as for the mesoblast trial results,were you underwhlemed by them or do you believe overall they were a success?

    MT79
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.5¢
Change
-0.070(6.57%)
Mkt cap ! $1.136B
Open High Low Value Volume
$1.04 $1.04 99.5¢ $3.980M 3.944M

Buyers (Bids)

No. Vol. Price($)
8 56239 99.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 103125 2
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.